Journal
HEPATOLOGY RESEARCH
Volume 47, Issue 1, Pages 60-69Publisher
WILEY
DOI: 10.1111/hepr.12730
Keywords
biomarker; HBV; HCC; HCV; liver fibrosis; miRNA
Categories
Funding
- Japan Society for the Promotion of Science [25293177]
- Ministry of Health, Labor and Welfare
- KOSEI-KAKENHI [H25-B sou-Kan-en-general-018]
- Grants-in-Aid for Scientific Research [25293177] Funding Source: KAKEN
Ask authors/readers for more resources
MicroRNAs (miRNAs) are a group of small non-coding RNAs that range in length from 20 to 25 nucleotides. MicroRNAs are specific for multiple cellular functions, including cell generation, differentiation, multiplication, carcinogenesis, and apoptosis. Many researchers have recently reported that the aberrant expression of miRNAs in hepatic tissue was related to the pathogenesis of liver disease, including viral hepatitis, hepatocellular carcinoma, and fatty liver disease. Multiple studies have proposed that an analysis of circulating miRNAs may be useful for diagnosing etiologies or staging the progression of liver disease, as well as for therapeutic purposes, for example, nucleic acid therapy. This review summarizes and discusses recent advances in the knowledge of miRNAs for chronic liver diseases, with special interest in viral hepatitis, liver fibrosis, and biomarkers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available